Regeneron Pharmaceuticals | REGN - Srodki Pieniężne I Ekwiwalent

Cena Akcji
731.77
Dzienna Zmiana
-12.67 -1.70%
Miesięcznie
-2.34%
Rocznie
28.63%
Q2 Prognozy TE
735.49




Srodki Pieniężne I Ekwiwalent Zmiana Data
AbbVie USD 5.23B 400M 2025-12
Agenus USD 3.46M 6.08M 2025-09
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amgen USD 9.13B 316M 2025-12
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 8.14B 1.08B 2025-09
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.3B 303M 2025-09
Incyte USD 4.02B 435.22M 2026-03
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
J&J USD 21.69B 1.98B 2026-03
Kyowa Hakko Kirin JPY 234.6B 20.23B 2025-06
Merck USD 18.17B 10.16B 2025-09
Moderna USD 2.6B 1.46B 2025-12
Neurocrine Biosciences USD 713M 372.8M 2025-12
Novartis USD 11.44B 1.88B 2025-12
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
Puma Biotechnology USD 53.52M 1.14M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
United Therapeutics USD 1.56B 217M 2025-12
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12